相关实验视频

Updated: Jul 16, 2025

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70

Published on: August 9, 2019

血清阿尔伯明通过影响细胞反应减轻了 perfluorooctane sulfonate 诱导的细胞毒性

Ya-Di Yang¹, Jia-Xin Li¹, Naihao Lu¹

¹Jiangxi Key Laboratory of Green Chemistry, College of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang 330022, China.

Biophysical chemistry

|September 23, 2023

概括

perfluorooctane sulfonate (PFOS) 与人血清白蛋白 (HSA) 结合,形成一个复合物,减少了PFOS的毒性. 这种蛋白质结合限制了PFOS的细胞吸收,并减轻了它对内皮细胞的有害影响.

科学领域:

环境科学环境科学
毒理学毒理学毒理学
生物化学生物化学

背景情况:

perfluorooctane sulfonate (PFOS) 是广泛使用的,但其毒性是一个越来越令人担忧的问题.
在体内,PFOS与专蛋白结合,但对毒性的影响还未得到充分研究.

研究的目的:

为了研究PFOS和人类血清白蛋白 (HSA) 之间的相互作用.
确定HSA-PFOS结合如何影响内皮细胞中的PFOS细胞毒性.

主要方法:

使用实验和理论方法研究PFOS-HSA相互作用.
毒性测定是在暴露于有或没有HSA的PFOS的内皮细胞上进行的.

主要成果:

通过键和范德瓦尔斯力,PFOS通过键和范德瓦尔斯力结合到HSA的Sudlow位点I.
HSA结合显著降低了PFOS细胞内吸收和亚细胞分布.
与HSA结合的PFOS显示抑制了活性氧物种的形成,并降低了内皮细胞的毒性.

结论:

结合白蛋白可以通过调节细胞反应来减轻PFOS毒性.
蛋白质复合的PFOS表现出降低的生物可用性和环境毒理学.
这凸显了白蛋白对PFOS诱导的健康风险的保护作用.

关键词:

细胞毒性细胞毒性互动互动互动互动 perfluorooctane 硫酸盐的使用情况血清白蛋白是如何形成的

更多相关视频

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats

Published on: April 17, 2013

相关概念视频

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...